BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY)

About BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S (BVNRY)

Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.

BAVARIAN NORDIC R/I S/ADR by Bavarian Nordic A/S News